ThermoGenesis Holdings, Inc. (THMO)
Key metrics
Financial statements
Free cash flow per share
-0.7926
Market cap
4.8 Thousand
Price to sales ratio
0.0006
Debt to equity
7.7610
Current ratio
0.5240
Income quality
0.2121
Average inventory
1.3 Million
ROE
-9.5965
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies. It markets and sells its medical device products through independent distributors, as well as direct to end-user customers. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.
News
globenewswire.com
3 months ago
AURORA, Colo., March 10, 2025 (GLOBE NEWSWIRE) -- Losing weight can often feel like an uphill battle, with conflicting advice and complicated diets making the process overwhelming. However, a simple yet effective method has been gaining traction in weight loss—the Ice Water Hack . When combined with Aqua Sculpt , a cutting-edge thermogenic formula, this straightforward technique can be a helpful addition to a balanced diet and regular exercise routine. It amplifies the body's fat-burning capabilities through thermogenesis. By strategically using cold exposure to enhance metabolic function, individuals can burn more calories, activate brown fat, and accelerate weight loss quickly and confidently. It's important to remember that weight loss is a journey that requires commitment and consistency, and while the Ice Water Hack and Aqua Sculpt can be beneficial, they are not a 'quick fix' or 'miracle solution' to weight loss.
globenewswire.com
3 months ago
AURORA, Colo., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Ice Water Hack stands at the core of a rapidly rising weight-loss phenomenon that, according to Dr. Blaine—a leading advocate of metabolic research—reveals why diets and workouts so often disappoint. Instead of blaming willpower, Dr. Blaine argues that most individuals have a metabolism stuck in “off” mode for much of the day. By harnessing the unique synergy of Aqua Sculpt, this 7-second Ice Water Hack instructs people to swallow a specialized capsule with ice-cold water upon waking—seemingly flipping the body's “fat-burning switch” for hours thereafter.
investorplace.com
a year ago
ThermoGenesis (NASDAQ: THMO ) stock is taking a beating on Wednesday after the company announced an update on its listing compliance. According to a ThermoGenesis filing, it has received another delisting notice from the Nasdaq Exchange.
seekingalpha.com
2 years ago
ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications, IR Dr. Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day.
prnewswire.com
2 years ago
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
prnewswire.com
2 years ago
Conference Call to be Held on November 13, 2023 RANCHO CORDOVA, Calif. , Nov. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the third quarter ended September 30, 2023, and provide a corporate strategic update on Thursday, November 13, 2023, after the close of trading.
prnewswire.com
2 years ago
An ISO 7 cGMP Cleanroom Facility Grand Opening On October 26, 2023 RANCHO CORDOVA, Calif. , Oct. 26, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and cell and gene therapy services, announced the grand opening of its new state-of-the-art facility, housing ISO 7 cGMP cleanroom suites, along with research and development labs.
prnewswire.com
2 years ago
RANCHO CORDOVA, Calif. , Sept. 6, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D.
seekingalpha.com
2 years ago
Thermogenesis Holdings, Inc. (NASDAQ:THMO ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Paula Schwartz - IR, Rx Communications Group Chris Xu - CEO Jeff Cauble - CFO Conference Call Participants Sean Lee - H.C. Wainwright & Co. Operator Good day, and welcome to the ThermoGenesis Holdings conference call and webcast to review financial and operating results for the second quarter ended June 30, 2023.
prnewswire.com
2 years ago
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
See all news